Brivlera (brivaracetam)

pCPA File Number: 20965

Negotiation Status:

Concluded with an LOI

Indication(s):

Epilepsy, partial-onset seizures

Sponsor/Manufacturer:

UCB Canada Inc.

CDA-AMC Project Number:

SR0484-000

pCPA Engagement Letter Issued:

2017-05-29

Negotiation Process Concluded:

2018-10-22